- Home
- SLNO vs SXT Comparison
SLNO vs SXT Comparison
Compare SLNO & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- SXT
- Stock Information
- Founded
- SLNO 1999
- SXT 1882
- Country
- SLNO United States
- SXT United States
- Employees
- SLNO N/A
- SXT N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SXT Major Chemicals
- Sector
- SLNO Health Care
- SXT Industrials
- Exchange
- SLNO Nasdaq
- SXT Nasdaq
- Market Cap
- SLNO 3.7B
- SXT 4.0B
- IPO Year
- SLNO 2014
- SXT N/A
- Fundamental
- Price
- SLNO $46.98
- SXT $93.29
- Analyst Decision
- SLNO Strong Buy
- SXT Buy
- Analyst Count
- SLNO 9
- SXT 2
- Target Price
- SLNO $114.89
- SXT $110.00
- AVG Volume (30 Days)
- SLNO 2.2M
- SXT 445.3K
- Earning Date
- SLNO 11-04-2025
- SXT 10-31-2025
- Dividend Yield
- SLNO N/A
- SXT 1.76%
- EPS Growth
- SLNO N/A
- SXT 56.32
- EPS
- SLNO N/A
- SXT 3.27
- Revenue
- SLNO $98,675,000.00
- SXT $1,595,084,000.00
- Revenue This Year
- SLNO N/A
- SXT $4.42
- Revenue Next Year
- SLNO $181.30
- SXT $5.78
- P/E Ratio
- SLNO N/A
- SXT $28.49
- Revenue Growth
- SLNO N/A
- SXT 4.25
- 52 Week Low
- SLNO $41.50
- SXT $66.15
- 52 Week High
- SLNO $90.32
- SXT $121.54
- Technical
- Relative Strength Index (RSI)
- SLNO 31.94
- SXT 46.48
- Support Level
- SLNO $66.12
- SXT $90.01
- Resistance Level
- SLNO $69.99
- SXT $96.82
- Average True Range (ATR)
- SLNO 3.71
- SXT 3.78
- MACD
- SLNO -2.47
- SXT 0.28
- Stochastic Oscillator
- SLNO 18.57
- SXT 31.44
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About SXT Sensient Technologies Corporation
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.